Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Parasite researchers win Nobel Prize
Mosquito
"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases” - Nobel assembly.
Awarded for work on malaria and roundworm therapies

The 2015 Nobel Prize in physiology or medicine has been awarded to three researchers for their contributions in developing novel therapies against malaria and roundworm parasite infection.

According to the Guardian, William Campbell and Satoshi Omura were awarded for their work on a therapy against roundworm, shared jointly with Tu Youyou, for a therapy against malaria.

In a statement published by Healio, the Nobel assembly said: "Diseases caused by parasites have plagued humankind for millennia and constitute a major global health problem. In particular, parasitic diseases affect the world’s poorest populations and represent a huge barrier to improving human health and well-being.

"This year’s Nobel Laureates have developed therapies that have revolutionised the treatment of some of the most devastating parasitic diseases.”

Tu discovered the life saving malaria ingredient by extracting the active ingredient of a traditional herbal medicine.

The component, later called artemisinin, targets the parasites during an early stage of their development. It is highly effective in both animals and humans, and is estimated to reduce the number of deaths caused by malaria by over 20 per cent.

Satoshi Omura's research explored the isolation and culture of several new strains of Streptomyces, which are known to have antibacterial qualities.

These were later acquired by William Campbell, who discovered that one of the cultures was effective against parasite infection in animals.  

This led to the discovery of avermectin and its derivative, Mectizan, which has contributed to the global fight against parasitic diseases such as river blindness and onchocerciasis.

Christopher Plowe, president of the American Society of Tropical Medicine and Hygiene, said:  “This year’s Prize recognises scientists who isolated compounds from bacteria and plants and developed them into drugs that have saved countless lives from malaria and prevented millions of cases of blindness and disfiguring swelling from parasitic worms worldwide.

“These three scientists have had a massive positive impact on global health. This was a great choice by the Nobel Committee.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.